Skip to main content

Amphotericin b cholesteryl sulfate Pregnancy and Breastfeeding Warnings

Brand names: Amphotec

Amphotericin b cholesteryl sulfate Pregnancy Warnings

Amphotericin B cholesteryl sulfate has been assigned to pregnancy category B by the FDA. Animal studies failed to reveal evidence of fetal harm. There are no controlled data in human pregnancy. Amphotericin B cholesteryl sulfate should be given during pregnancy only when benefit outweighs risk.

See references

Amphotericin b cholesteryl sulfate Breastfeeding Warnings

There are no data on the excretion of amphotericin B cholesteryl sulfate into human milk. Due to the potential for serious adverse effects in a nursing infant, a decision should be made to discontinue nursing or discontinue the drug, taking into consideration the importance of the drug to the woman.

See references

See also

References for pregnancy information

  1. Product Information. Amphotec (amphotericin B cholesteryl sulfate). Sequus Pharmaceuticals Inc. 2022.
  2. Product Information. Ambisome (amphotericin B liposomal) Nexstar Pharmaceuticals, San Dimas, CA.

References for breastfeeding information

  1. Product Information. Amphotec (amphotericin B cholesteryl sulfate). Sequus Pharmaceuticals Inc. 2022.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer